Atlas Trials

A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis

Clinical trial NCT00257855 · COMPLETED

Trial details

NCT number
NCT00257855
Sponsor
University College London Hospitals
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Secondary Progressive Multiple Sclerosis
Start date
2005-11-01
Primary completion
2009-01-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.